Tissue Engineering And Nanotheranostics

“9.61x6.69” b2815 Tissue Engineering and Nanotheranostics

Engineering Approaches for Creating Skeletal Muscle 21

3. Heydemann A, McNally EM. Consequences of disrupting the dystro-
   phinsarcoglycan complex in cardiac and skeletal myopathy. Trends
   Cardiovasc. Med. 17 (2), 55–59 (2006).


4. Deconinck N, Dan B. Pathophysiology of duchenne muscular dystro-
   phy: Current hypotheses. Pediatr. Neurol. 36 (1), 1–7 (2007).


5. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L,
   Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F,
   Tomezsko J, Constantin C. Diagnosis and management of duchenne
   muscular dystrophy, part 1: Diagnosis, and pharmacological and psycho-
   social management. The Lancet Neurology 9 (1), 77–93 (2010).


6. Kohler M, Clarenbach CF, Bahler C, Brack T, Russi EW, Bloch KE.
   Disability and survival in duchenne muscular dystrophy. J. Neurol.
   Neurosurg. Psychiatry. 80 (3), 320–325 (2009).


7. Florian A, Rösch S, Bietenbeck M, Engelen M, Stypmann J, Waltenberger
   J, Sechtem U, Yilmaz A. Cardiac involvement in female duchenne and
   becker muscular dystrophy carriers in comparison to their first-degree
   male relatives: a comparative cardiovascular magnetic resonance study.
   Eur. Heart J. Cardiovasc. Imaging 17 (3), 326–333 (2016).


8. Romitti PA, Zhu Y, Puzhankara S, James KA, Nabukera SK, Zamba
   Gideon KD, Ciafaloni E, Cunniff C, Druschel CM, Katherine D, Dennis
   MJ, Matthews F, Meaney J, Andrews JG, Caspers Conway KM, Fox DJ,
   Street N, Adams MM, Bolen J. Prevalence of duchenne and becker mus-
   cular dystrophies in the United States. Pediatr. 135(3), 513–521 (2015).


9. Morley JE, Thomas DR, Wilson M-MG. Cachexia: Pathophysiology and
   clinical relevance. Am. J. Clin. Nutr. 83 (4), 735–743 (2006).


10. Malafarina V, riz Otano F, Iniesta R, Gil-Guerrero L. Sarcopenia in the
    elderly: Diagnosis, physiopathology and treatment. Maturitas. 71 (2),
    109–114 (2012).


11. Gr ogan BF, Hsu JR. Volumetric muscle loss. J. Am. Acad. Orthop. Surg.
    19 , s35+ (2011).


12. Aur ora A, Garg K, Corona BT, Walters TJ. Physical rehabilitation
    improves muscle function following volumetric muscle loss injury. BMC
    Sports Sci. Med. Rehabili. 6 , 41 (2014).


13. Kraybill WG, Pollock RE, Chao AH, Mayerson JL, Chandawarkar R,
    Scharschmidt TJ. Surgical management of soft tissue sarcomas: Extremity
    sarcomas. J. Surg. Oncol. 111 , 540+ (2015).


14. Baoge L, Van Den Steen E, Rimbaut S, Philips N, Witvrouw E, Almqvist
    KF, Vanderstraeten G, Vanden Bossche LC. Treatment of skeletal mus-
    cle injury: A review. ISRN Orthop. 2012 : 7 (2012).

b2815_Ch-01.indd 21 11-10-2017 06:32:17 PM